Related by context. All words. (Click for frequent words.) 73 systemic lupus erythematosus 72 lupus nephritis 70 autoantibody positive 69 ADPKD 69 juvenile idiopathic arthritis JIA 69 chronic lymphocytic leukemia CLL 69 juvenile idiopathic arthritis 69 T1DM 68 Systemic lupus erythematosus SLE 68 leukemia AML 68 rheumatoid arthritis RA 68 hepatocellular carcinoma HCC 68 T2DM 68 CMV infection 68 Gleevec resistant 68 PsA 67 acute myelogenous leukemia AML 67 AAT deficiency 67 HeFH 67 castrate resistant prostate cancer 67 basal cell carcinoma BCC 67 psoriatic arthritis PsA 67 Hodgkin lymphoma HL 67 Severe Primary IGFD 67 Rheumatoid Arthritis RA 67 erythematosus 67 relapsing remitting multiple sclerosis 67 SHPT 67 myelofibrosis polycythemia vera 66 acute leukemias 66 Chronic lymphocytic leukemia 66 vWD 66 Crohn disease CD 66 refractory gout 66 diabetes mellitus DM 66 Systemic Lupus Erythematosus SLE 66 chronic myeloid 66 hypereosinophilic syndrome 66 disease NAFLD 66 Bronchiectasis 66 Sjögren syndrome 65 Acute Myeloid Leukemia AML 65 systemic juvenile idiopathic 65 chronic eosinophilic leukemia 65 essential thrombocythemia 65 selective modulator 65 gastrointestinal stromal tumors GIST 65 leukemia ALL 65 systemic fungal infections 65 sodium glucose cotransporter 65 AA Amyloidosis 65 Parkinson disease PD 65 Sezary syndrome 65 chronic periodontitis 65 hypercalcemia 65 polycystic ovary syndrome PCOS 65 Zolinza 65 dyskinesia PD LID 65 MGd 65 K ras mutations 65 gastrointestinal stromal tumor GIST 65 endometrial hyperplasia 65 familial ALS 65 canakinumab 65 hypoparathyroidism 65 invasive candidiasis 65 relapsed MM 65 herpes zoster shingles 65 metastatic renal cell carcinoma 65 efalizumab 65 myeloproliferative neoplasms 65 colorectal carcinoma 65 elevated triglyceride levels 65 vasomotor symptoms 65 chronic prostatitis 65 colorectal cancer CRC 65 CANCIDAS 65 pan HDAC inhibitor 65 basal cell nevus syndrome 65 ABCB1 64 myeloproliferative diseases 64 Vaprisol 64 Cutaneous T 64 plasma kallikrein 64 Rheumatoid arthritis RA 64 HuLuc# 64 Systemic Lupus Erythematosus 64 AA amyloidosis 64 nonalcoholic steatohepatitis NASH 64 atopic eczema 64 Adalimumab 64 macroalbuminuria 64 cell lymphoma CTCL 64 recurrent glioblastoma multiforme 64 metastatic neuroendocrine tumors 64 LHON 64 pheochromocytoma 64 Juvenile Idiopathic Arthritis 64 rheumatoid arthritis psoriatic arthritis 64 disorder FSAD 64 erlotinib Tarceva ® 64 herpes zoster 64 chronic immune thrombocytopenic 64 Epratuzumab 64 dasatinib Sprycel 64 leukemia CLL 64 follicular lymphoma FL 64 epithelial tumors 64 MAGE A3 ASCI 64 SJIA 64 toenail onychomycosis 64 receptor tyrosine kinase inhibitor 64 Ofatumumab 64 anterior uveitis 64 diabetic nephropathy 64 neurological manifestations 64 atypical hemolytic uremic syndrome 64 prostate cancer CaP 64 CYT# potent vascular disrupting 64 heterozygous FH 64 pancreatic NET 64 PAOD 64 secondary hyperparathyroidism 64 myelodysplastic myeloproliferative diseases 64 hyperphenylalaninemia HPA due 64 LymphoStat B belimumab 64 Haptoglobin 64 Natalizumab 64 familial amyloidotic polyneuropathy FAP 64 YONDELIS 64 lupus erythematosus 64 Myelofibrosis 64 biologic therapy 64 Dasatinib 64 Myelodysplastic syndromes MDS 63 rheumatic diseases 63 gastric carcinoma 63 noninfectious uveitis 63 acne vulgaris 63 Major depressive disorder 63 idiopathic thrombocytopenic purpura ITP 63 decompensated liver disease 63 non metastatic osteosarcoma 63 non alcoholic steatohepatitis 63 imatinib resistant 63 gefitinib Iressa 63 kidney urologic 63 Chronic Lymphocytic Leukemia CLL 63 Psoriatic arthritis 63 AAT Deficiency 63 hematologic disorders 63 HER2 overexpression 63 Carcinoid tumors 63 dysglycemia 63 primary hypercholesterolemia 63 painful diabetic neuropathy 63 hepatocellular cancer 63 idiopathic PAH 63 CIMZIA ™ 63 PD LID 63 overt nephropathy 63 recurrent ovarian cancer 63 2 diabetes T2D 63 visilizumab 63 haematologic 63 ANCA associated 63 polycythemia vera PV 63 MGUS 63 chronic granulomatous disease 63 Alzheimer Disease AD 63 leukaemias 63 Clusterin 63 vidofludimus 63 Hematologic 63 primary Restless Legs 63 fibromyalgia syndrome 63 Traficet EN 63 Vidaza azacitidine 63 diabetes mellitus T2DM 63 Lubiprostone 63 schizophrenia CIAS 63 homozygous familial hypercholesterolemia 63 primary biliary cirrhosis 63 APTIVUS r 63 quinolone 63 neuroendocrine cancers 63 immunocompetent 63 somatostatin analogue 63 PCNSL 63 recurrent NSCLC 63 MELAS 63 chronic plaque psoriasis 63 acute GvHD 63 rheumatic disease 63 Malignant Melanoma 63 PEGylated anti 63 HbF 63 MALT lymphoma 63 INCB# [003] 63 pancreatic neuroendocrine tumors 63 ankylosing spondylitis AS 63 ACTEMRA TM 63 overactive bladder OAB 63 grade cervical intraepithelial 63 eosinophilic asthma 63 progressive neurodegenerative disorder 63 proliferative diabetic retinopathy 63 constipation OIC 63 neoplasm 63 NOMID 63 hepatorenal syndrome 63 terlipressin 63 relapsing multiple sclerosis 63 epithelial ovarian cancer 63 Pulmonary Arterial Hypertension PAH 63 HER2 positive metastatic breast 63 Atopic dermatitis 63 indolent NHL 63 Lupus nephritis 63 pulmonary hypertension PH 63 Tasimelteon 63 irritable bowel syndrome IBS 63 Leukemias 63 GISTs 63 myeloproliferative 63 Hypoactive Sexual Desire Disorder 63 acute myeloid leukemia AML 63 squamous cell carcinoma SCC 63 purpura ITP 63 carcinoid 63 subclinical hypothyroidism 63 medullary thyroid cancer 63 familial hypercholesterolemia 63 RoACTEMRA 63 Cloretazine 63 evaluating tivozanib 62 JAK inhibitors 62 T#I [002] 62 rituximab Rituxan 62 hyperprolactinemia 62 TNF Tumor Necrosis Factor 62 atopic asthma 62 relapsed ovarian cancer 62 chemotherapy induced neutropenia 62 ovarian carcinoma 62 myelodysplastic syndrome MDS 62 Amrubicin 62 CD# monoclonal antibody 62 diabetes mellitus 62 PKC# 62 relapsing remitting MS RRMS 62 subependymal giant cell 62 Evoltra ® 62 pancreatic adenocarcinoma 62 hypoxia inducible factor 62 alkylating agent 62 Leber Hereditary Optic Neuropathy 62 discoid lupus 62 GH deficiency 62 hepatitis C genotype 62 imatinib Gleevec ® 62 Maribavir 62 imatinib Gleevec 62 IL 1ß 62 ACTEMRA 62 polyarticular 62 adalimumab Humira 62 atopic dermatitis AD 62 chronic HBV infection 62 Belimumab 62 knee osteoarthritis OA 62 herpesviruses 62 metastatic malignant 62 dyslipidaemia 62 Golimumab 62 diabetic neuropathic pain 62 posaconazole 62 mixed hyperlipidemia 62 erythropoietic 62 panitumumab Vectibix 62 imatinib resistance 62 benign prostatic hypertrophy BPH 62 gastric adenocarcinoma 62 relapsing remitting 62 overactive bladder syndrome 62 decitabine 62 chronic myeloid leukemia CML 62 symptomatic BPH 62 Romiplostim 62 serous ovarian cancer 62 thalidomide Thalomid 62 BCR ABL inhibitors 62 Bucindolol 62 chronic HCV infection 62 transthyretin amyloidosis 62 Decitabine 62 hepatitis C HCV 62 LRP5 62 atrophic gastritis 62 Lupus Nephritis 62 stage IIIB 62 vinca alkaloid 62 pouchitis 62 Ribavirin causes 62 Alzheimer disease AD 62 bendamustine 62 prostate cancer PCa 62 Symadex 62 atopic 62 Sapacitabine 62 relapsed refractory multiple myeloma 62 G6PD deficiency 62 phenylketonuria PKU 62 leukemia CML 62 FOLOTYN ® 62 cutaneous T 62 nucleotide analog 62 treat benign prostatic 62 bronchogenic carcinoma 62 post herpetic neuralgia PHN 62 IBS C 62 chronic idiopathic thrombocytopenic purpura 62 diabetic gastroparesis 62 complement inhibitor eculizumab 62 Hepatocellular Carcinoma HCC 62 recurrent genital herpes 62 VaD 62 myasthenia gravis MG 62 VEGF inhibitors 62 bacterial vaginosis BV 62 ulcerative colitis UC 62 cIAI 62 oral prodrug 62 IMiDs ® compound 62 factor TNF 62 Primary IGFD 62 relapsing MS 62 deletion 5q 62 thrombophilia 62 non Hodgkin lymphomas 62 systolic hypertension 62 AEG# 62 rheumatoid arthritis juvenile idiopathic 62 primary immunodeficiency PI 62 mycophenolate mofetil 62 T2D 62 Beta catenin pathway 62 TEAEs 62 proteinuria 62 NAGS deficiency 62 thromboembolic disease 62 lymphoproliferative disorder 62 SPRYCEL ® 62 HoFH 62 Gorlin syndrome 62 riociguat 62 lymphocytosis 61 narcolepsy cataplexy 61 HIV HCV coinfected 61 HBeAg negative 61 superficial bladder cancer 61 Ankylosing spondylitis 61 metastatic malignant melanoma 61 Epstein Barr virus EBV 61 TACI Ig 61 APOE e4 61 Crohn disease 61 idiopathic pulmonary fibrosis IPF 61 candidemia 61 atopic dermatitis 61 Atopic Dermatitis 61 relapsed multiple myeloma 61 Janus kinase 61 Enzastaurin 61 Fludara ® 61 leukoencephalopathy 61 interferon gamma 1b 61 acute promyelocytic leukemia APL 61 lomitapide 61 Retinitis Pigmentosa RP 61 SSc 61 Hereditary angioedema HAE 61 proliferative retinopathy 61 CP CPPS 61 diagnosed Ph + 61 CC genotype 61 denileukin diftitox 61 Advanced Renal Cell 61 Etanercept 61 Hashimoto thyroiditis 61 chlorambucil 61 teriflunomide 61 1 diabetes T1D 61 advanced metastatic renal 61 pediatric Crohn disease 61 Pathway Inhibitor 61 oral candidiasis 61 de novo AML 61 breast carcinoma 61 CIMZIA TM certolizumab pegol 61 HBeAg positive 61 chronic ITP 61 Diabetic Macular Edema 61 Hepatocellular Carcinoma 61 Actemra tocilizumab 61 Rheumatoid arthritis 61 immune modulator 61 CIN3 61 histologic subtype 61 postherpetic neuralgia 61 Epothilones 61 latent tuberculosis infection 61 CMV disease 61 trans retinoic acid 61 psoriasis 61 aHUS 61 Diffuse Large B 61 carcinoid tumors 61 diarrhea predominant irritable 61 premenstrual syndrome PMS 61 trabectedin 61 Laquinimod 61 Glioblastoma Multiforme GBM 61 MTHFR 61 severe malignant osteopetrosis 61 Prostatitis 61 severe hypersensitivity reactions 61 ALT flares 61 Acute lymphoblastic leukemia 61 Kit CD# positive 61 hepatocellular carcinoma 61 Major Depressive Disorder MDD 61 pathologic myopia 61 metaglidasen 61 quetiapine Seroquel 61 mTOR mammalian target 61 nucleoside analogs 61 allogeneic bone marrow 61 idiopathic thrombocytopenic purpura 61 Aortic stenosis 61 immune thrombocytopenic purpura 61 aripiprazole Abilify 61 DFMO 61 non squamous NSCLC 61 IFN beta 61 anti androgen 61 cytogenetic responses 61 Voreloxin 61 esophageal candidiasis 61 HQK 61 atypical Hemolytic Uremic Syndrome 61 EGFR HER2 61 demyelinating 61 familial hypercholesterolemia FH 61 hypersensitivity reaction 61 acute myeloid 61 CTAP# Capsules 61 Bcr Abl mutations 61 MPS IVA 61 cutaneous squamous cell carcinoma 61 KRAS mutations occur 61 atherogenic dyslipidemia 61 euthymic patients 61 Osteoarthritis OA 61 Duchenne muscular dystrophy DMD 61 multiple myeloma MM 61 mixed dyslipidemia 61 primary generalized tonic 61 hypercholesterolaemia 61 Enzyme Replacement Therapy 61 severe renal impairment 61 ZOLINZA 61 severe psoriasis 61 post operative ileus 61 myelofibrosis MF 61 NATRECOR R 61 ORENCIA ® 61 dyskeratosis congenita 61 Phenoptin 61 sorafenib Nexavar 61 Sym# 61 erlotinib Tarceva 61 ritonavir boosted 61 cutaneous T cell 61 EGFR inhibitors 61 SNT MC# 61 Chronic Fatigue Syndrome CFS 61 interstitial cystitis 61 Genentech Rituxan 61 TTR amyloidosis 61 either acutely decompensated 61 Candida infection 61 thetreatment 61 somatostatin analog 61 severe neutropenia 61 Inflammatory bowel disease 61 DPNP 61 metastatic RCC 61 MPS VI 61 non splenectomized 61 BARACLUDE ® 61 Myelodysplastic syndromes 61 infliximab Remicade 61 thyrotoxicosis 61 testicular germ cell 61 Chronic Myelogenous Leukemia CML 61 B7 H3 61 haloperidol Haldol 61 LHRH antagonists 61 constipation predominant irritable bowel 61 biliary tract cancer 61 vWF 61 proteasome inhibitor 61 refractory chronic lymphocytic 61 myeloproliferative disorders 61 Idiopathic Thrombocytopenic Purpura ITP 61 Hypercholesterolemia 61 onset diabetes mellitus 61 autosomal dominant 61 hematopoietic cancers 61 Benign Prostatic Hyperplasia BPH 61 pathophysiological effects 61 asthma rhinitis 61 TMS Therapy 61 cilengitide 61 Rilonacept 61 Esophagitis 61 SGPT 61 refractory anaplastic astrocytoma 61 nucleoside analog 61 skeletal metastases 61 depsipeptide 61 unstable angina UA 61 GW# [003] 61 HER2 positive cancers 61 renal insufficiency 61 Chronic Lymphocytic Leukemia 61 Blinatumomab 61 Leukine ® 61 Polycystic ovary syndrome PCOS 61 syndrome RLS 61 GnRH agonists 61 extrapyramidal symptoms 61 formerly LymphoStat B 61 alemtuzumab treated 61 rheumatoid arthritis 61 HBV infection 61 HCV infection 61 JAK2 enzyme 61 myeloid metaplasia 61 galiximab 61 lymphoma CTCL 61 choroidal neovascularization 61 Virulizin ® 61 colorectal adenoma 61 varicella zoster virus 61 hA# 61 Diabetic nephropathy 61 bone metastasis 61 humanized interleukin 6 61 generalized epilepsy 61 Tocilizumab 61 post herpetic neuralgia 61 Archexin 61 cytomegalovirus infection 61 ON #.Na 61 Nilotinib 61 mycosis fungoides 61 gastrointestinal stromal tumors GISTs 61 HNSCC 61 Talabostat 61 venlafaxine Effexor 61 glycated hemoglobin levels 61 receptor inhibitor 61 Gleevec imatinib mesylate 60 systemic scleroderma 60 caspofungin 60 airway hyperresponsiveness 60 atopic disorders 60 VZV 60 mTOR inhibitor 60 hematopoietic cell 60 Cell Lymphoma 60 immunomodulatory therapy 60 tocilizumab 60 interferon alfa 60 ospemifene 60 EBV infection 60 Chronic Myeloid Leukemia 60 urinary incontinence UI 60 neurogenic orthostatic hypotension 60 Lymphocytic 60 Fabry Disease 60 Degarelix 60 cinacalcet 60 Friedreich Ataxia FRDA 60 adverse reactions ≥ 60 Ophena TM 60 Cimzia ® certolizumab pegol 60 peritumoral brain edema 60 Omacetaxine 60 Plicera 60 bronchopulmonary dysplasia BPD 60 synovial cells 60 hyperplasia BPH 60 HuMax EGFr 60 metastatic gastric 60 tuberous sclerosis complex 60 Irritable Bowel Syndrome IBS 60 menopausal symptom 60 Cimzia R 60 idiopathic myelofibrosis 60 anemias 60 Velcade bortezomib 60 mRCC 60 medulloblastomas 60 pseudobulbar affect PBA 60 Epidermal Growth Factor Receptor 60 unipolar depression 60 malignant lymphoma 60 Teriflunomide 60 TNF antagonist 60 breast cancer subtypes 60 leukotriene receptor antagonist 60 VAPRISOL 60 dasatinib Sprycel ® 60 autoantibodies 60 antithrombotics 60 octreotide LAR 60 histone deacetylase HDAC inhibitor 60 Acute myeloid leukemia 60 monogenic 60 HGS ETR2 60 SNT-MC#/idebenone 60 oral leukoplakia 60 osteoarthritis OA 60 seropositive patients 60 posterior uveitis 60 Zavesca R 60 Dapagliflozin 60 acute humoral rejection 60 Safinamide 60 monoclonal anti 60 tumor histology 60 LHRH receptor positive 60 DPP4 60 allergic asthma 60 erythematosus SLE 60 Glucocorticoids 60 HER2 expression 60 chronic myelogenous leukemia CML 60 primary hyperparathyroidism 60 chronic HBV 60 MKC# MT 60 alpha interferons 60 NOXAFIL 60 urticaria hives 60 poor metabolizers 60 hypertriglyceridemia 60 myeloid 60 pediatric acute lymphoblastic 60 progressive PsA 60 Lenalidomide 60 FGFR1 60 attention-deficit/hyperactivity disorder ADHD 60 metastatic GIST 60 AGHD 60 dexamethasone Decadron 60 Irritable bowel syndrome IBS 60 chronic hepatitis cirrhosis 60 gastrointestinal stromal tumors 60 vildagliptin 60 RAPTIVA 60 insulin sensitizers 60 sJIA 60 parkinsonism 60 recurrent VTE 60 hereditary antithrombin deficiency 60 Allergic Rhinitis 60 amnestic mild cognitive impairment 60 desvenlafaxine succinate 60 Candesartan 60 mTOR inhibitors 60 osteosarcomas 60 paroxysmal nocturnal hemoglobinuria 60 carcinoid tumor 60 placebo controlled clinical 60 docetaxel Taxotere ® 60 patientswith 60 velafermin 60 Relapsed Refractory 60 virus HCV infection 60 Cholangiocarcinoma 60 abacavir Ziagen 60 FSAD 60 renal cell carcinomas 60 MYLOTARG 60 juvenile myoclonic epilepsy 60 symptomatic paroxysmal AF 60 cisplatin chemotherapy 60 fibrotic disease 60 tyrosine kinase inhibitors TKIs 60 myelodysplastic syndromes MDS 60 hypothalamic amenorrhea 60 IMiDs 60 BCG refractory 60 elotuzumab 60 HCD# [002] 60 IPL# 60 sporadic ALS 60 opioid induced bowel dysfunction 60 Idiopathic Pulmonary Fibrosis IPF 60 cutaneous melanoma 60 anti CD3 antibody 60 subcutaneously administered 60 Systemic Juvenile Idiopathic 60 lymphoid malignancies 60 androgenetic alopecia 60 Denufosol 60 myeloperoxidase 60 nasopharyngeal carcinoma 60 AVODART 60 sunitinib malate 60 fallopian tube carcinoma 60 Chronic HCV 60 chronic rhinosinusitis CRS 60 MYH9 gene 60 pulmonary metastases 60 inflammatory acne 60 RhuDex R 60 AGILECT ® 60 GAMMAGARD 60 Restless Legs Syndrome RLS 60 Darapladib 60 XmAb# 60 Sudhir Agrawal D.Phil 60 Interferon alpha 60 azacitidine 60 Heavy menstrual bleeding 60 microtubule inhibitor 60 varicella zoster virus VZV 60 metastatic colorectal 60 intravenous bisphosphonates 60 dermatologic reactions 60 infantile spasms 60 rufinamide 60 diabetic macular edema DME 60 heavily pretreated 60 Chronic Heart Failure 60 serum phosphate 60 null responder 60 syngeneic 60 interleukin IL -# 60 VA# [002] 60 Tavocept 60 HuMax CD4 60 Acute myeloid leukemia AML 60 AGILECT R 60 retinal vein occlusion 60 CIPN 60 invasive aspergillosis 60 TREDAPTIVE 60 gastrointestinal GI motility disorders 60 Irinotecan 60 Endometrial cancer 60 daunorubicin 60 Vidaza ® 60 homozygous FH 60 prostate cancer CRPC 60 prolonged QT interval 60 allogeneic stem cell 60 nociceptive pain 60 epithelial ovarian 60 myelofibrosis 60 HLA DR2 60 metformin sulfonylurea 60 ACZ# 60 relapsed leukemia 60 hypercholesterolemia 60 chronic hepatitis C. 60 advanced adenoma 60 chlamydial infection 60 hypocalcaemia 60 LRAT 60 CRVO 60 paricalcitol 60 bexarotene 60 alkylating 60 endocrine therapies 60 IL #E 60 paragangliomas 60 PRTX 60 NXL# 60 pulmonary infiltrates 60 dapsone 60 cytomegalovirus CMV 60 neovascular diseases 60 vemurafenib 60 vandetanib 60 Leber congenital amaurosis LCA 60 cervical intraepithelial neoplasia 60 cytogenetic abnormalities 60 glioblastoma multiforme GBM 60 Azedra 60 acetonide FA 60 superficial basal cell carcinoma 60 induced macular edema 60 diabetic kidney 60 rilonacept 60 EXJADE 60 antibody MAb 60 mGluR5 NAM 60 carcinoid syndrome 60 haematological toxicity 60 immunodeficiencies 60 paroxetine Paxil 60 postoperative ileus 60 IMiDs ® 60 oral antidiabetic medication 60 Kinoid 60 proliferator activated receptor 60 Akt inhibitor 60 Pharmacokinetics PK 60 6R BH4 60 sorafenib Nexavar ® 60 phase IIb clinical 60 inhibitor RG# 60 anticancer therapy 60 Prodarsan ® 60 generalized anxiety disorder GAD 60 hyperglycaemia 60 Pseudomonas aeruginosa infections 60 Major Depressive Disorder 60 pericardial effusion 60 prostate cancer HRPC 60 mGlu2 3 60 nonsmall cell lung cancer 60 intravenous cyclophosphamide 60 Nonalcoholic fatty liver 60 recurrent glioblastoma 60 dopaminergic therapy 60 EGFR tyrosine kinase inhibitors 60 papillary renal cell carcinoma 60 osteoporotic vertebral fractures 60 hypovitaminosis D 60 Neutropenia 60 benign prostatic hypertrophy 60 perimenopausal women 60 Iron deficiency anemia 60 basiliximab 60 Systemic Sclerosis 60 small molecule thrombopoietin 60 synthetic retinoid 60 recurrent wheezing 60 Eltrombopag 60 Multiple sclerosis MS 60 Xanafide 60 sulfasalazine 60 EGFR mutation 60 allogeneic HSCT 60 imatinib mesylate 60 Raptiva R 60 histological subtype 60 POAG 60 giant cell arteritis 60 overactive bladder symptoms 60 REMINYL ® 60 hyperkalemia 60 HNPCC 60 Obstructive sleep apnea 60 Rituxan rituximab 60 orally administered inhibitor 60 eribulin mesylate 60 Acute Decompensated Heart Failure 60 Myelodysplastic Syndrome MDS 60 anemia hemoglobin 60 Systemic lupus erythematosus 59 Juvenile Idiopathic Arthritis JIA 59 Acute Myeloid Leukaemia AML 59 bronchial hyperresponsiveness 59 relapsed ALL 59 KRAS status 59 diagnostic biomarker 59 Ceflatonin 59 STRIDE PD 59 neuropsychiatric symptoms 59 Soft Tissue Sarcoma 59 Hemophilia B 59 GvHD 59 ziprasidone Geodon 59 neovascular 59 skeletal muscle weakness 59 NAFLD 59 GNAQ 59 plaque psoriasis 59 malignant pleural mesothelioma 59 type 1diabetes 59 mapatumumab 59 relapsed refractory AML 59 colorectal liver metastases 59 lymphoma subtypes 59 adenocarcinomas 59 sunitinib Sutent ® 59 Amigal 59 HER2 positive breast cancer 59 DDP# 59 keloid scarring 59 atherothrombosis 59 debilitating autoimmune 59 ependymomas 59 Morquio 59 OAB symptoms 59 Provectus Pharmaceuticals specializes 59 hepatocellular carcinomas 59 TNFalpha 59 refractory metastatic colorectal cancer 59 transplantation HCT 59 pegylated interferons 59 sorafenib tablets 59 receiving VELCADE 59 IRX 2 59 INVEGA ® 59 leiomyomas 59 Omalizumab 59 chronic hepatitis B. 59 sodium thiosulfate STS 59 Pemetrexed 59 Toxicities 59 Cushing Syndrome 59 Genasense ® 59 malignant neoplasm 59 refractory NSCLC 59 EFFEXOR XR 59 LymphoStat B 59 gouty arthritis 59 recurrent glioma 59 hereditary hemochromatosis 59 neuropsychiatric disorder 59 primary IGFD 59 INSPIRE Trial Phase III 59 progressive psoriatic arthritis 59 dilated cardiomyopathy DCM 59 urothelial carcinoma 59 MCyR 59 Noxafil 59 Parkinson Disease PD 59 chimeric monoclonal antibody 59 phase IIb trial 59 cutaneous lupus 59 smoldering myeloma 59 Acute Radiation Syndrome ARS 59 AVAPRO 59 CEQ# 59 opioid induced constipation OIC 59 PTEN mutations 59 TYGACIL 59 Alzhemed TM 59 osteoporotic vertebral compression fractures 59 adalimumab 59 lymphomas 59 transaminase elevations 59 apoptotic pathway 59 HGS ETR1 mapatumumab 59 severe gastroparesis 59 fungoides 59 HBeAg negative patients 59 arthritis PsA 59 immune modulatory 59 cell lymphoma ALCL 59 PDE4 inhibitor 59 Acute Bacterial Sinusitis ABS 59 latent celiac disease 59 taxane resistant 59 PTPN# 59 Elagolix 59 atopy 59 atherothrombotic disease 59 autoimmune thyroid 59 autoantibody levels 59 nucleoside analogue 59 Granulocyte Colony Stimulating Factor 59 pertuzumab 59 lysosomal storage diseases 59 Catena ® 59 lumbar spinal stenosis LSS 59 allograft rejection 59 serum IGF 59 LHRH agonist 59 biologic DMARD 59 haemolytic anemia 59 eosinophilic pneumonia 59 Recombinant interferon alpha 59 CHOP chemotherapy 59 C#Y 59 macrovascular disease 59 Angioedema 59 Nexavar sorafenib 59 TNF receptor 59 HBsAg